Kristie McNealy, MD

Since it’s both Prematurity Awareness Month and the start of RSV season for many of us here in the US, I thought I’d spend some time today talking about RSV and protecting your preemie once you leave the hospital.  Respiratory syncytial virus (RSV), is a common seasonal virus.  For most of the continental United States, [...]

Recent research has shown that late preterm birth is on the rise, and that these babies face significant health risks.  Not surprisingly, an additional study on late preterm birth has shown that late preterm babies, born between 33 and 35 weeks gestation, face significantly higher health care costs than their full-term peers.
The study, carried out [...]

Ever since Synagis (aka palivizumab) was brought to market by MedImmune, there has been debate over which babies should benefit from its RSV protection, and which should not. Synagis has been shown to reduce RSV related hospitalizations by 50%, it hasn’t been shown to reduce RSV related deaths, and while it is believed that [...]